Ardent
Ardent has developed technologies to transform “energy-storing” white adipose tissue (WAT) into “energy-burning” brown adipose tissue (BAT) for treatment of obesity, diabetes, and metabolic disease. Team: Luis Santos Brian Gillette
Read MoreMotion2Movement
A remote knee-therapy platform that enables patient engagement, and provides critical data to clinicians including muscle activation, therapy compliance and progress, and patient-reported outcomes. Team: Ralph Hertz, President Ankush Thakur, VP Mark Hase, VP Sam Tran, VP
Read MoreCalRegen, Inc.
CalRegen, Inc is a start-up biotechnology company formed on the discovery of calreticulin (CRT), as a novel biotherapeutic that has unique, diverse and broad ranging tissue regenerative qualities that will be developed for different indications including chronic wound healing, epidermal appendage (hair follicle) neogenesis, improving the cosmetic architecture of the skin, and healing of ophthalmic ulcers.…
Read MoreTEZCAT Biologics
TEZCAT is developing a biologics-based therapeutic approach to treat mutant Ras cancers, such as colorectal cancer. TEZCAT team: CEO – Alex Efron CSO – Craig Ramirez, Ph.D. Ops. Mgr – Andy Hauser, Ph.D.
Read More